Late Breaking Abstract - Rituximab limits the progression of fibrosing mediastinitis

C. Varghese (Rochester, United States of America), G. Johnson (Rochester, United States of America), P. Eiken (Rochester, United States of America), P. Tobias (Rochester, United States of America)

Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Session: Rare and ultra-rare diseases and the lungs: updates and new perspectives
Session type: Oral Presentation
Number: 5325

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Varghese (Rochester, United States of America), G. Johnson (Rochester, United States of America), P. Eiken (Rochester, United States of America), P. Tobias (Rochester, United States of America). Late Breaking Abstract - Rituximab limits the progression of fibrosing mediastinitis. 5325

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: